748211000001100: Ladropen 250mg capsules (Teva UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ladropen 250mg capsules (Teva UK Ltd)
\UK product\Virtual medicinal product\Flucloxacillin 250mg capsules\Ladropen 250mg capsules (Teva UK Ltd)
\UK product\Virtual therapeutic moiety\Flucloxacillin\Flucloxacillin 250mg capsules\Ladropen 250mg capsules (Teva UK Ltd)
\UK product\Trade family\Ladropen\Ladropen 250mg capsules (Teva UK Ltd)

\Medicinal product\Medicinal product categorized by disposition\Medicinal product containing penicillinase-resistant penicillin and acting as antibacterial agent (product)\Product containing flucloxacillin\Flucloxacillin\Flucloxacillin 250mg capsules\Ladropen 250mg capsules (Teva UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Product containing penicillin (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Medicinal product containing penicillinase-resistant penicillin and acting as antibacterial agent (product)\Product containing flucloxacillin\Flucloxacillin\Flucloxacillin 250mg capsules\Ladropen 250mg capsules (Teva UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Medicinal product containing penicillinase-resistant penicillin and acting as antibacterial agent (product)\Product containing flucloxacillin\Flucloxacillin\Flucloxacillin 250mg capsules\Ladropen 250mg capsules (Teva UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Medicinal product containing penicillinase-resistant penicillin and acting as antibacterial agent (product)\Product containing flucloxacillin\Flucloxacillin\Flucloxacillin 250mg capsules\Ladropen 250mg capsules (Teva UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16064901000001112 Ladropen 250mg capsules (Teva UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

16065001000001112 Ladropen 250mg capsules (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ladropen 250mg capsules (Teva UK Ltd)	Is a	Product containing precisely flucloxacillin 250 milligram/1 each conventional release oral capsule	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Is a	Flucloxacillin 250mg capsules	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Is a	Flucloxacillin 250mg capsules	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has active ingredient	Bactericide	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has active ingredient	Flucloxacillin	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has active ingredient	Flucloxacillin sodium	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has active ingredient	Substance with antibacterial mechanism of action	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has active ingredient	Flucloxacillin sodium	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has manufactured dose form	Oral dose form	false	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Is a	Ladropen	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Flucloxacillin	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has specific active ingredient	Flucloxacillin sodium	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has manufactured dose form	Conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd)	Has basis of strength substance	Flucloxacillin	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ladropen 250mg capsules (Teva UK Ltd) 28 capsule 2 x 14 capsules	Is pack of	False	Ladropen 250mg capsules (Teva UK Ltd)	Inferred relationship	Existential restriction modifier
Ladropen 250mg capsules (Teva UK Ltd) 28 capsule 2 x 14 capsules	Has AMP	True	Ladropen 250mg capsules (Teva UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16064901000001112	Ladropen 250mg capsules (Teva UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
16065001000001112	Ladropen 250mg capsules (Teva UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module